Generative AI May Significantly Reduce Number Of Animal Experiments

Researchers are exploring how generative AI can help identify new active substances in early drug development phases, potentially reducing reliance on animal testing. This technological advancement addresses the ethical dilemma of animal experimentation while maintaining rigorous scientific standards. The shift toward AI-driven discovery could accelerate medical breakthroughs while aligning with growing ethical concerns.